About
Company Management
Meet Our Team
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Careers
Technologies
REQORSA® Immunogene Therapy
GPX-002 and GPX-003
ONCOPREX® Nanoparticle Delivery System
Programs
Oncology Combination Treatment Approach
Lung Cancer
Diabetes
Clinical Trials
Pipeline
ONC-001
ONC-002
Acclaim-1
Acclaim-2
DIA-001
Expanded Access Policy
Investors
Overview
Company Profile
Stock Information
SEC Filings
Analyst Coverage
Corporate Governance
Shareholder FAQ
Downloads
Events
News
Press Releases
Blog Posts
Media Coverage
Videos
Email Alerts
Contact
About
Company Management
Meet Our Team
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Careers
Technologies
REQORSA® Immunogene Therapy
GPX-002 and GPX-003
ONCOPREX® Nanoparticle Delivery System
Programs
Oncology Combination Treatment Approach
Lung Cancer
Diabetes
Clinical Trials
Pipeline
ONC-001
ONC-002
Acclaim-1
Acclaim-2
DIA-001
Expanded Access Policy
Investors
Overview
Company Profile
Stock Information
SEC Filings
Analyst Coverage
Corporate Governance
Shareholder FAQ
Downloads
Events
News
Press Releases
Blog Posts
Media Coverage
Videos
Email Alerts
Contact
© 2024 © 2020 Genprex Inc. All Rights Reserved.
Company
Management
Ryan M. Confer, MS
President, Chief Executive Officer, Chief Financial Officer
Mark Berger, M.D.
Chief Medical Officer
Thomas Gallagher, Esq.
Senior Vice President of Intellectual Property & Licensing
David M. Schloss
Senior Vice President of Human Resources
Suzanne Thornton-Jones, Ph.D.
Senior Vice President, Regulatory Affairs and Quality
